130 related articles for article (PubMed ID: 3661551)
21. A comparison between oral ciprofloxacin and intraperitoneal vancomycin and netilmicin in CAPD peritonitis.
Tapson JS; Orr KE; George JC; Stansfield E; Bint AJ; Ward MK
J Antimicrob Chemother; 1990 Dec; 26 Suppl F():63-71. PubMed ID: 2292546
[TBL] [Abstract][Full Text] [Related]
22. Initial treatment of dialysis associated peritonitis: a controlled trial of vancomycin versus cefazolin.
Flanigan MJ; Lim VS
Perit Dial Int; 1991; 11(1):31-7. PubMed ID: 2049420
[TBL] [Abstract][Full Text] [Related]
23. Long-term, intraperitoneal vancomycin in the prevention of recurrent peritonitis during CAPD: preliminary results.
Lam TY; Vas SI; Oreopoulos DG
Perit Dial Int; 1991; 11(3):281-2. PubMed ID: 1912025
[No Abstract] [Full Text] [Related]
24. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
25. Intraperitoneal vancomycin and ceftazidime in the treatment of CAPD peritonitis.
Gray HH; Goulding S; Eykyn SJ
Clin Nephrol; 1985 Feb; 23(2):81-4. PubMed ID: 3886227
[TBL] [Abstract][Full Text] [Related]
26. Vancomycin administration in continuous ambulatory peritoneal dialysis: the risk of ototoxicity.
Gendeh BS; Gibb AG; Aziz NS; Kong N; Zahir ZM
Otolaryngol Head Neck Surg; 1998 Apr; 118(4):551-8. PubMed ID: 9560111
[TBL] [Abstract][Full Text] [Related]
27. Peritoneal dialysis catheter replacement: "save the patient and not the catheter".
Piraino B
Semin Dial; 2003; 16(1):72-5. PubMed ID: 12535305
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H
Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942
[TBL] [Abstract][Full Text] [Related]
29. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
[TBL] [Abstract][Full Text] [Related]
30. Vancomycin and ceftazidime in the treatment of CAPD peritonitis.
Beaman M; Solaro L; McGonigle RJ; Michael J; Adu D
Nephron; 1989; 51(1):51-5. PubMed ID: 2644565
[TBL] [Abstract][Full Text] [Related]
31. [Monitoring of intraperitoneal administration of vancomycin in patients on continuous ambulatory peritoneal dialysis].
Montañés-Pauls B; Alós Almiñana M; Casabó Alós VG; García Pérez H
Farm Hosp; 2012; 36(5):328-35. PubMed ID: 22264836
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis.
Morse GD; Farolino DF; Apicella MA; Walshe JJ
Antimicrob Agents Chemother; 1987 Feb; 31(2):173-7. PubMed ID: 3566247
[TBL] [Abstract][Full Text] [Related]
33. Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients.
Mulhern JG; Braden GL; O'Shea MH; Madden RL; Lipkowitz GS; Germain MJ
Am J Kidney Dis; 1995 Apr; 25(4):611-5. PubMed ID: 7702059
[TBL] [Abstract][Full Text] [Related]
34. Single-dose pharmacokinetics of intraperitoneal ofloxacin in patients on continuous ambulatory peritoneal dialysis.
Cheng IK; Chau PY; Kumana CR; Chan CY; Kou M; Siu LK
Perit Dial Int; 1993; 13 Suppl 2():S383-5. PubMed ID: 8399617
[TBL] [Abstract][Full Text] [Related]
35. A comparison between oral ciprofloxacin and intra-peritoneal vancomycin and gentamicin in the treatment of CAPD peritonitis.
Bennett-Jones DN; Russell GI; Barrett A
J Antimicrob Chemother; 1990 Dec; 26 Suppl F():73-6. PubMed ID: 2292547
[TBL] [Abstract][Full Text] [Related]
36. Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis-Related Peritonitis: A Randomized Controlled Pilot Study.
Xu R; Yang Z; Qu Z; Wang H; Tian X; Johnson DW; Dong J
Am J Kidney Dis; 2017 Jul; 70(1):30-37. PubMed ID: 28027794
[TBL] [Abstract][Full Text] [Related]
37. Intraperitoneal vancomycin/oral pefloxacin versus intraperitoneal vancomycin/gentamicin in the treatment of continuous ambulatory peritoneal dialysis peritonitis.
Lye WC; Lee EJ; van der Straaten J
Perit Dial Int; 1993; 13 Suppl 2():S348-50. PubMed ID: 8399607
[TBL] [Abstract][Full Text] [Related]
38. Intraperitoneal teicoplanin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis.
Bowley JA; Pickering SJ; Scantlebury AJ; Ackrill P; Jones DM
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():133-9. PubMed ID: 2965125
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis.
Millikin SP; Matzke GR; Keane WF
Perit Dial Int; 1991; 11(3):252-60. PubMed ID: 1832968
[TBL] [Abstract][Full Text] [Related]
40. Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.
Neal D; Bailie GR
Clin Pharmacokinet; 1990 Jun; 18(6):485-90. PubMed ID: 2354591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
